$SAN #Sanofi SANOFI: Fitusiran maintains efficacy over 2.6 years | BUY - Top Picks | EUR107(+16%): SANOFI - BUY - Top Picks | EUR107(+16%) Fitusiran maintains efficacy over 2.6 years Same efficacy than at 20 months Competition with… https://t.co/1z16laGAlS #equity #stocks https://t.co/LCRNUKwxiD